REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 26th, 2019 • Arvinas, Inc. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (the “Agreement”) is entered into as of this 26th day of September 2018, by and among Arvinas, Inc. (f/k/a Arvinas Holding Company, LLC), a Delaware corporation (the “Company”), the holders of the Company’s shares of Series A Preferred Stock (the “Series A Shares”), shares of Series B Preferred Stock (the “Series B Shares”) and shares of Series C Preferred Stock (the “Series C Shares” and, together with the Series A Shares and the Series B Shares, the “Preferred Shares”) listed on Exhibit A attached hereto (collectively, the “Investors”).
AMENDMENT NO. 4Exclusive License Agreement • March 26th, 2019 • Arvinas, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO.4, effective as of January 9, 2019 (this “AMENDMENT”), to a certain Exclusive License Agreement dated July 5, 2013, and as amended on May 8, 2014, Oct. 23rd, 2014, and April 1, 2015 (the “LICENSE AGREEMENT”) by and between ARVINAS OPERATIONS, INC. (formerly known as Arvinas, Inc.) , a Delaware corporation having an office at 5 Science Park, 3rd Floor, New Haven, CT 06511 (“Arvinas”) and Yale University, a corporation organized and existing under and by virtue of a charter granted by the general assembly of the Colony and the State of Connecticut and located at 433 Temple St, New Haven, CT 06511 (“Yale”).
Restricted Stock Unit AgreementRestricted Stock Unit Agreement • March 26th, 2019 • Arvinas, Inc. • Pharmaceutical preparations • Delaware
This grant of RSUs satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities.
